Boston Scientific Corporation

BSX · NYSE
Analyze with AI
Key StatsIncome StatementBalance SheetCash Flow
AnnualQuarterly
KMB
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets––––
Cash & Equivalents–$534$725$414
Short-Term Investments–$0$0$0
Receivables–$2,815$2,693$2,558
Inventory–$2,861$2,867$2,810
Other Curr. Assets–$911$1,050$1,138
Total Curr. Assets–$7,121$7,335$6,920
Property Plant & Equip (Net)–$3,952$3,837$3,744
Goodwill–$18,076$17,340$17,089
Intangibles–$7,259$6,565$6,684
Long-Term Investments–$626$655$555
Tax Assets–$3,778$3,676$3,655
Other NC Assets–$746$732$749
Total NC Assets–$34,437$32,805$32,476
Other Assets–$1$0-$1
Total Assets–$41,559$40,140$39,395
Liabilities––––
Payables–$962$1,004$960
Short-Term Debt–$480$777$1,778
Tax Payable–$173$294$268
Deferred Revenue–$313$306$306
Other Curr. Liab.–$3,262$2,677$3,087
Total Curr. Liab.–$5,190$5,058$6,399
LT Debt–$11,547$10,931$9,369
Deferred Rev, NC–$349$335$329
Deferred Tax Liab, NC–$226$158$155
Other NC Liab.–$1,594$1,212$1,140
Total NC Liab.–$13,716$12,636$10,993
Other Liabilities–$0$0$0
Cap. Leases–$566$525$527
Total Liabilities–$18,906$17,694$17,392
Equity––––
Pref Stock–$0$0$0
Common Stock–$17$17$17
Retained Earnings–$4,144$3,347$2,673
AOCI–-$722-$28$275
Other Equity–$18,979$18,876$18,805
Total Equity–$22,418$22,212$21,770
Supplemental Information––––
Minority Interest–$235$233$233
Total Liab. & Tot. Equity–$41,559$40,140$39,395
Net Debt$0$11,493$10,983$10,733